Bromide

Bromide

SCHEMBL1883010

Cc1ccc(CCC[n+]2cc[nH]c2)cc1.[Br-]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CHKA known ✓ P35790 2/20 0.42
▸ CHRNA7 P36544 2/20 0.46
▸ CHRNA10 Q9GZZ6 2/20 0.46
▸ CHRNA9 Q9UGM1 2/20 0.46
▸ HRH1 P35367 1/20 0.37
▸ IGF1R P08069 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2A6 P11509 1/20 0.36
▸ TAAR1 Q96RJ0 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL1889476 0.84 CHRNA7 (0.40) CHRNA7CHRNA10CHRNA9CHKATAAR1
Bromide SCHEMBL1887326 0.84 CHRNA7 (0.40) CHRNA7CHRNA10CHRNA9TAAR1
Bromide SCHEMBL1885288 0.84 CHRNA7 (0.40) CHRNA7CHRNA10CHRNA9CHKAHRH1
Bromide SCHEMBL1882691 0.83 CALM1 (0.45) CHRNA7CHRNA10CHRNA9IGF1RALOX15
SCHEMBL5297631 0.81 SIGMAR1 (0.39) CHRNA7CHRNA10CHRNA9
SCHEMBL15367679 0.81 CHKA (0.48) CHKACYP1A2CYP2A6TAAR1
Hydrochloric Acid SCHEMBL20923487 0.80 SIGMAR1 (0.38) CHRNA7CHRNA10CHRNA9
Water SCHEMBL28218483 0.80 CHKA (0.47) CHKACYP1A2CYP2A6TAAR1
Bromide SCHEMBL1886050 0.78 KCNJ1 (0.46) HRH3KCNH2
Bromide SCHEMBL1889458 0.77 HRH3 (0.37) CHRNA7CHRNA10CHRNA9HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9260397-B2 Salts comprising aryl-alkyl-substituted imidazolium and triazolium cations and the use thereof TECHNISCHE UNIVERSITAET DRESDEN (DE) 2016-02-16 — — US disclosed
US-20110105761-A1 Salts Comprising Aryl-Alkyl-Substituted Imidazolium and Triazolium Cations and the Use Thereof TECHNISCHE UNIVERSITAET DRESDEN (DE) 2011-05-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105761-A1 Salts Comprising Aryl-Alkyl-Substituted Imidazolium and Triazolium Cations and the Use Thereof RDX, HAX1, CHRM2 CHKA 2372/4885CHRNA7 264/4885CHRNA10 418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback